P
Per Venge
Researcher at Uppsala University
Publications - 457
Citations - 34544
Per Venge is an academic researcher from Uppsala University. The author has contributed to research in topics: Eosinophil cationic protein & Eosinophil. The author has an hindex of 86, co-authored 454 publications receiving 33109 citations. Previous affiliations of Per Venge include University of Helsinki & Karolinska Institutet.
Papers
More filters
Journal Article
Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice
TL;DR: A multimarker strategy with creatinine clearance, troponin, CRP and NT-proBNP together with ischemic ECG changes and clinical background characteristics provides the best prognostic information for choice of treatment in patients with unstable coronary artery disease.
Journal Article
BNP eller NT-proBNP bör analyseras vid misstänkt hjärtsvikt : Riktlinjer för analys och tolkning
Tomas Jernberg,Kurt Boman,Stefan James,Bertil Lindahl,Mats Stridsberg,Karl Swedberg,Per Venge +6 more
TL;DR: Available data indicate that the use of B-type natriuretic peptide (BNP) or N-terminal-proBNP (NT-proPNP) improve the diagnostics of suspected heart failure as compared to the currently used clinic treatments.
Journal ArticleDOI
T6 Acute exacerbations of chronic obstructive pulmonary disease: identification of phenotype-specific biomarkers and biological clusters
Mona Bafadhel,S McKenna,Sarah Terry,Vijay Mistry,C Reid,Pranabashis Haldar,M McCormick,Koirobi Haldar,Tatiana Kebadze,Annelyse Duvoix,K Lindbald,Paul Rugman,P Dodson,Martin Jenkins,Paul Newbold,Per Venge,Ruth H. Green,David A. Lomas,Michael R. Barer,Sebastian L. Johnston,Ian D. Pavord,C E Brightling +21 more
TL;DR: In this paper, the presence of biological phenotypes of COPD exacerbations and biomarker associations with pathogens and inflammation were investigated, and four biological clusters were identified which validated the subgroups of exacerbations associated with bacteria, virus or sputum eosinophilia.
Journal ArticleDOI
HNL Dimer- A Specific Biomarker of Neutrophil Activity - In Sepsis and Antibiotics Monitoring. A Mini-Review
TL;DR: The potential usefulness, and superiority to current biomarkers, of plasma measurements of HNL Dimer in the monitoring of antibiotics in patients with sepsis are shown.